E2A t(1;19)(q23;p13) Qualitative Genetic Test
Comprehensive Genetic Testing for Leukemia Diagnosis
The E2A t(1;19)(q23;p13) Qualitative test represents a cutting-edge advancement in genetic oncology diagnostics, specifically designed to detect chromosomal abnormalities associated with acute lymphoblastic leukemia (ALL). This sophisticated molecular test utilizes Real Time PCR technology to identify the precise genetic translocation between chromosomes 1 and 19, providing clinicians with essential information for accurate leukemia diagnosis and treatment planning.
What This Test Detects and Measures
This specialized genetic test specifically identifies the t(1;19)(q23;p13) chromosomal translocation, which results in the fusion of the E2A gene on chromosome 19 with the PBX1 gene on chromosome 1. This genetic abnormality:
- Detects the E2A-PBX1 fusion gene formation
- Identifies specific chromosomal breakpoints at q23 and p13
- Measures the presence of this leukemia-associated genetic marker
- Provides qualitative results indicating the presence or absence of the translocation
Who Should Consider This Test
The E2A t(1;19)(q23;p13) Qualitative test is recommended for individuals experiencing:
- Unexplained fatigue, weakness, or persistent tiredness
- Frequent infections or unusual bruising/bleeding
- Bone pain or joint discomfort without apparent cause
- Enlarged lymph nodes, spleen, or liver
- Unexplained weight loss or night sweats
- Patients with suspected or newly diagnosed acute lymphoblastic leukemia
- Individuals requiring treatment monitoring or disease progression assessment
Key Benefits of Genetic Testing
Choosing the E2A t(1;19)(q23;p13) Qualitative test provides numerous advantages for comprehensive leukemia management:
- Accurate Diagnosis: Provides definitive identification of specific genetic abnormalities
- Treatment Guidance: Helps oncologists develop personalized treatment strategies
- Prognostic Information: Offers insights into disease progression and potential outcomes
- Minimal Sample Requirement: Requires only 2ml EDTA blood sample
- Rapid Results: Turnaround time of just 3-4 days for timely decision-making
- Cost-Effective: Available at an affordable discounted price of $112 USD
Understanding Your Test Results
Your E2A t(1;19)(q23;p13) Qualitative test results will provide clear guidance:
- Positive Result: Indicates the presence of the E2A-PBX1 fusion gene, confirming the specific genetic abnormality associated with certain types of ALL
- Negative Result: Suggests the absence of this particular translocation, though other genetic abnormalities may still be present
- Clinical Correlation: Results should always be interpreted by your healthcare provider in the context of your complete medical picture
- Follow-up Testing: Additional genetic testing may be recommended based on your results and clinical presentation
Test Pricing and Availability
| Test Name | Regular Price | Discount Price |
|---|---|---|
| E2A t(1;19)(q23;p13) Qualitative Test | $150 USD | $112 USD |
Nationwide Testing Availability
GGC DNA provides comprehensive genetic testing services across all major cities in the United States. Our state-of-the-art laboratories and collection centers are conveniently located in:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and the Midwest region
- Houston, Dallas, and Texas metropolitan areas
- Miami, Orlando, and Florida locations
- All other major US cities and metropolitan regions
Take Action for Your Health Today
Don’t wait to get the critical genetic information you need for proper leukemia diagnosis and treatment. Our experienced genetic counselors and healthcare professionals are ready to assist you with:
- Comprehensive test explanation and preparation guidance
- Convenient sample collection at locations near you
- Fast, accurate results within 3-4 business days
- Professional interpretation and follow-up recommendations
Book your E2A t(1;19)(q23;p13) Qualitative test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Take the first step toward comprehensive genetic cancer diagnosis and personalized treatment planning.
